The patent landscape for a potential COVID-19 treatment
Introduction Since the outbreak of the COVID-19 pandemic began in 2020, it…
The sleeping giant of nanomedicine
Nanomedicine applies the tools and knowledge of nanotechnology for the…
The next frontier: prescribing a breath of fresh air!
In this world of lockdowns and working from home it is important to dedicate…
Should we trust vaccines or not?
The first COVID-19 vaccines have been administered in several countries around…
When it comes to COVID-19, a “nose job” might do the trick
Injectable COVID-19 vaccines may not be the only preventative measure against…
Healthcare cybersecurity during and after COVID-19
Since the healthcare industry entered the digital transformation era, it has…
Implementing Digital the right way
In the last few years, pharma has been very loud about the ways it is going to…
Human impact on the environment and the risk of developing disease
The human impact on the environment is expected to have complex effects on…
COVID-19 impact on clinical trials
The COVID-19 pandemic bears a burden to the clinical trials sector, which is…
Covid-19 vaccine distribution: A roadmap for the poor countries?
Even before the official approval was given, the United States and European…
Lessons learned by Pharma during the pandemic
From cities under lockdown to the most affected areas, the coronavirus pandemic…